| Old Articles: <Older 2631-2640 Newer> |
 |
Pharmaceutical Executive January 1, 2006 Davenport & Fisher |
Sales Force Survey Base pay is up and incentives are easier to earn as the pharmaceuticals industry tries to hang onto top performers and attract new talent.  |
Pharmaceutical Executive January 1, 2006 Bill Shearer |
Patient Assistant Programs and Medicare Part D About 2.5 million low-income seniors who participate in prescription access programs are eligible for drug coverage under Medicare Part D - but the programs are out of alignment.  |
Pharmaceutical Executive January 1, 2006 Michael Fronstin |
A Fresh Look at Co-morbidity You may think you understand a disease. But then it arrives in tandem. A new survey takes a fresh look at co-morbidity.  |
Pharmaceutical Executive January 1, 2006 Maggie Helmig |
Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors.  |
Pharmaceutical Executive January 1, 2006 Gene Guselli |
Marketing to Professionals: The Power of Positive Feedback Boost doctors' confidence in your brand by validating their prescription decisions.  |
Pharmaceutical Executive January 1, 2006 Gina Ashe |
Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands.  |
Pharmaceutical Executive January 1, 2006 Peter Thompson |
Sales Management: The Wonders of Wireless Pharmaceutical reps can recover 30 minutes of downtime everyday with 24/7 connectivity to the Internet.  |
Pharmaceutical Executive January 1, 2006 Lou Morris |
Back Page: Nailing Down DTC Promotion Before the FDA and industry can find a solution to direct to consumer promotion, they need to nail down the problem.  |
Pharmaceutical Executive January 1, 2006 Jill Wechsler |
Washington Report: PDUFA Blues The Prescription Drug User Fee Act is up for reauthorization. Let the games begin.  |
Pharmaceutical Executive January 1, 2006 Patrick Clinton |
From the Editor: A Wild 25 This has been an amazing quarter century for the pharmaceuticals industry, and it has brought us to a point at which the next quarter century can only be more of the same  |
| <Older 2631-2640 Newer> Return to current articles. |